The Sunshine Act and oncology: Lessons learned from urology.

ABSTRACT:

Introduction

The Physician Payment Sunshine Act was enacted to increase the transparency of financial relationships between physicians and the pharmaceutical industry. These financial relationships are prevalent in the field of oncology, as they are in other fields of medicine. We explored the relationship between industry and urologists for compensations associated with the treatment of urologic malignancies.

Methods

The publicly available Open Payments database was obtained from the Centers for Medicare & Medicaid Services. We performed a descriptive analysis of payments made to urologists for drugs associated with urologic malignancies.

Results

In total, 44,334 payments, summing to $ 4,638,856, were made to 5,666 urologists for drugs used to treat urologic cancers.

SUBMITTER: Maruf M 

PROVIDER: S-EPMC8171588 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature